Cookies and the protection of your data

We use cookies to improve the functionality of the website, to offer you a better website experience and to provide social media features. You give your consent by clicking on “Accept all Cookies” or as part of your individual settings. Please find detailed information on the use of cookies on this website in our Data Privacy Statement.

Functional Cookies

These cookies are necessary for the operation of the site and enable security-relevant functions. In addition, we determine whether you want to remain logged in and to make our services available to you when you change between this and other websites.

Statistical Cookies

These cookies are used for analyzing user behavior on our website with the aim of improving user navigation. All data collected is evaluated anonymously. Further information is available on our data protection site.

Marketing Cookies

These cookies are used to deliver relevant advertising or to limit how many times you see an ad. Marketing cookies can share that information with the advertiser (third-party cookies). The legal basis for the data processing is the consent of the user.

iF DESIGN AWARD
About the iF Design AwardiF JurySustainabilityBenefitsiF Design Award NightLifetime Achievement AwardFAQ
WINNERS & iF RANKING
iF Design Winners 2025All Winners since 1954iF Design RankingBrands & Creatives
STUDENT AWARD
Overview2024 WinnersJurorsBenefitsSponsorsFAQ
SOCIAL IMPACT PRIZE
OverviewJurorsWhat is Social Impact?Supported Projects since 2017Success StoriesFAQ
MAGAZINE
All ArticlesiF NewsletterPodcastTrend Report

BACK TO RESULTS (0)

Liverly - Mixed Reality Liver Disease Therapeutics
Liverly - Mixed Reality Liver Disease Therapeutics
Liverly - Mixed Reality Liver Disease Therapeutics
Liverly - Mixed Reality Liver Disease Therapeutics
Liverly - Mixed Reality Liver Disease Therapeutics
Liverly - Mixed Reality Liver Disease Therapeutics
Liverly - Mixed Reality Liver Disease Therapeutics
Liverly - Mixed Reality Liver Disease Therapeutics
Liverly - Mixed Reality Liver Disease Therapeutics
Liverly - Mixed Reality Liver Disease Therapeutics
2025

Share:

Liverly - Mixed Reality Liver Disease Therapeutics

Mixed Reality Spatial Therapeutics

Ni Design

Liverly is one of the first mixed reality therapeutic tools in the world designed for Nonalcoholic Fatty Liver Disease (NAFLD), a chronic condition affecting 32% of the global population with no pharmaceutical treatments available. Liverly offers a unique, non-invasive experience that harnesses advanced research in circadian rhythm and autophagy to support liver health. Through interactive, personalized visualizations, users engage with scientifically-backed strategies for proactive liver wellness. Liverly’s spatial therapeutics approach empowers users to take charge of their liver health in a groundbreaking way.

Client / Manufacturer

Ni Design

Los Angeles, CA, US
Design

Zehui Ni

Los Angeles, CA, US
Date of Launch
2024
Development Time
up to 12 Month
Target Regions
Australia / Oceania, Europe, North America
Target Groups
Consumers / Users

RELATED PROJECTS